Preliminary Programme |
|
Advanced Search |
|
|
Print |
Back |
Hall | Session Title | Session Type | 11:00 - 12:00 | AUDITORIUM | OPENING OF THE CONGRESS | | | | |
| 12:00 - 12:45 | AUDITORIUM | ADVANCES IN TECHNOLOGY, PIONEERING NEW PRACTICES IN NOCTURNAL HYPERTENSION ASSESSMENT IN PATIENTS AT RISK | Mini-symposium supported by Omron | | | |
| 12:00 - 13:00 | ROOM 1 | EFFECTIVE PRECISION DIAGNOSIS AND THERAPIES OF HYPERTENSION FOR CLINICIANS | Joint Session ESH-ISH-POA | | | |
| 12:00 - 12:45 | ROOM 2 | QUESTIONS AT THE START OF HYPERTENSION TREATMENT IN CLINICAL PRACTICE: A CASE-BASED INTERACTIVE SESSION
| Mini-symposium supported by an unrestricted educational grant from Sanofi
| | | |
| 12:00 - 13:00 | ROOM 3 | GENETICS AND DISEASE MODEL GUIDED NOVEL THERAPEUTIC TARGET DISCOVERY IN HYPERTENSION | 19th International SHR Symposium | | | |
| 12:00 - 14:00 | ROOM 4 | BIHS Symposium | | | | |
| 12:00 - 13:00 | ROOM 5 | SUPPORTING ROUTINE ASSESSMENT OF COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS: A POSITION PAPER OF THE WG | ESH Working Group on Hypertension and the Brain | | | |
| 12:30 - 13:30 | ROOM 6 | ESH Working Group on Interventional Treatment of Hypertension | | | | |
| 13:00 - 14:00 | AUDITORIUM | THE EVOLUTION OF HYPERTENSION MANAGEMENT: THE INCREASING ROLE OF TRIPLE THERAPY IN CLINICAL PRACTICE
| Satellite Symposium supported by Servier | | | |
ROOM 1 | DEFINING A NOVEL APPROACH FOR VALIDATION OF NEW DEVICES FOR ARTERIAL STIFFNESS MEASUREMENT | ESH Working Group on Vascular Structure and Function | | | |
ROOM 2 | WOMEN A HIGH RISK POPULATION: REPRODUCTION, HORMONES AND CARDIOVASCULAR RISK | ESH Working Group on Obesity, Diabetes and the High Risk Patient | | | |
ROOM 3 | COMPREHENSIVE APPROACH FOR HYPERTENSION CONTROL IN AFRICA | ESH Working Group on Hypertension and cardiovascular risk assessment in subjects living in or emigrating from low resource settings | | | |
ROOM 5 | ESH Working Group on Cardiovascular Pharmacotherapy and Adherence | | | | |
| 13:30 - 14:30 | ROOM 6 | HYPERTENSION IS THE MOST IMPORTANT CAUSE OF HFpEF: MECHANISMS AND MANAGEMENT | ESH Working Group on Hypertension and the Heart | | | |
| 14:00 - 15:00 | AUDITORIUM | RENAL DENERVATION: A NOVEL APPROACH TO HYPERTENSION CARE | Satellite Symposium supported by Medtronic | | | |
ROOM 1 | HYPERTENSION IN YOUTH: NEW INSIGHTS | ESH Working Group on Hypertension in Children and Adolescents | | | |
ROOM 2 | ADVANCES ON DIAGNOSIS, PATHOPHYSIOLOGY AND TREATMENT OF HYPERTENSION IN PATIENTS WITH CKD | ESH Working Group on Hypertension and the Kidney | | | |
ROOM 3 | UNSOLVED ISSUES IN ENDOTHELIAL DYSFUNCTION IN ARTERIAL HYPERTENSION | ESH Working Group on Endothelins and Endothelial Factors | | | |
ROOM 4 | SEXUAL DYSFUNCTION AND ANTIHYPERTENSIVE THERAPY | ESH Working Group on Hypertension and Sexual Dysfunction | | | |
ROOM 5 | ISH Regional Advisory Group - Africa | | | | |
| 15:00 - 15:45 | AUDITORIUM | ELEVATED HEART RATE IN HYPERTENSIVE PATIENTS | Mini-symposium supported by Servier | | | |
ROOM 1 | PROTECTING THE BRAIN: WHY KIDNEYS MATTER?
| Mini-symposium supported by Bayer
| | | |
ROOM 2 | LESSON FROM THE COURTROOM | Mini-symposium supported by Menarini | | | |
| 15:00 - 16:00 | ROOM 3 | THE BALKAN SYMPOSIUM | | | | |
ROOM 4 | CARDIOVASCULAR RISK FACTORS | Parallel Oral Session 1A | | | |
ROOM 5 | ESH WORKING GROUP ON ENDOCRINE HYPERTENSION | | | | |
ROOM 6 | GENETICS, GENOMICS, PROTEOMICS, METABOLOMICS | Parallel Oral Session 1B | | | |
| 16:00 - 16:45 | AUDITORIUM | HITTING THE BULL'S-EYE IN HYPERTENSION MANAGEMENT | Mini-symposium supported by Menarini | | | |
ROOM 1 | IMPROVING CARDIORENAL OUTCOMES IN HYPERTENSION | Mini-symposium supported by an unrestricted educational grant from AstraZeneca | | | |
ROOM 2 | A REVIEW OF THE RADIANCE-HTN GLOBAL CLINICAL TRIAL PROGRAM: RENAL DENERVATION USING ULTRASOUND ABLATION
| Mini-symposium by ReCor Medical | | | |
| 16:00 - 17:00 | ROOM 4 | Late-Breakers Session | Parallel Oral Session | | | |
ROOM 5 | RESISTANT HYPERTENSION - INTEREVENTIONAL THERAPIES | Parallel Oral Session 2A | | | |
ROOM 6 | EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS | Parallel Oral Session 2B | | | |
|